$CTXR 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Results of Operations and Financial Condition Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
21 Aug 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 Aug 2026	8-K: Results of Operations and Financial Condition
05 Aug 2026	8-K: Other Events
01 Jun 2026	8-K: Other Events
15 May 2026	8-K: Results of Operations and Financial Condition
08 May 2026	8-K: Entry into a Material Definitive Agreement
29 Apr 2026	8-K: Unregistered Sales of Equity Securities; Other Events
24 Apr 2026	8-K: Entry into a Material Definitive Agreement; Other Events
06 Apr 2026	8-K: Submission of Matters to a Vote of Security Holders
31 Mar 2026	8-K: Other Events
10 Mar 2026	8-K: Other Events
04 Mar 2026	8-K: Other Events
13 Feb 2026	8-K: Results of Operations and Financial Condition; Notice of Delisting or Failure to Satisfy a Listing Rule
23 Dec 2025	8-K: Results of Operations and Financial Condition
01 Dec 2025	8-K: Regulation FD Disclosure; Other Events
23 Oct 2025	8-K: Regulation FD Disclosure
21 Oct 2025	8-K: Entry into a Material Definitive Agreement; Other Events
12 Aug 2025	8-K: Results of Operations and Financial Condition
08 Jul 2025	8-K: Other Events

Comments